Search results
Results from the WOW.Com Content Network
In the past 52 weeks, GlaxoSmithKline PLC share prices are bracketed by a low of $33.26 and a hi. GlaxoSmithKline PLC (NYSE: GSK) traded at a new 52-week high today of $42.68. This new high was ...
Stock pickers are generally looking for stocks that will outperform the broader market. And while active stock picking...
GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with headquarters in London. [3] [4] It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, [n 1] which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm.
For premium support please call: 800-290-4726 more ways to reach us
Dame Emma Natasha Walmsley DBE (born June 1969) is the chief executive officer (CEO) of GSK plc. [1] She succeeded Sir Andrew Witty, who retired in March 2017. [2] Before GSK, she worked for L'Oréal for 17 years, and was a non-executive director of Diageo until September 2016. [3]
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. [ 4 ] [ 5 ] The company's product portfolio includes prescription medicines and vaccines .
For premium support please call: 800-290-4726 more ways to reach us
Sir Andrew Philip Witty (born 22 August 1964) [1] is a British business executive and has been the chief executive officer (CEO) of UnitedHealth Group since 2021. He was the CEO of GlaxoSmithKline from 2008 to 2017.